Cargando…
COVID-19 should be a methylene blue “promoter”
Autor principal: | Evora, Paulo Roberto B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454620/ https://www.ncbi.nlm.nih.gov/pubmed/32864945 http://dx.doi.org/10.21470/1678-9741-1-2020-0607 |
Ejemplares similares
-
Methylene blue is not a pure vasoconstrictor drug
por: Evora, Paulo Roberto Barbosa
Publicado: (2016) -
COVID-19 and Methylene Blue
por: Wiwanitkit, Viroj
Publicado: (2021) -
Methylene blue as an anti-COVID-19 mouthwash in dental practice
por: Arakeri, Gururaj, et al.
Publicado: (2021) -
Methylene blue unresponsive methemoglobinemia
por: Mirakbari, Seyed Mostafa
Publicado: (2014) -
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)